LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
US Stock MarketDetailed Quotes
CME CME Group
- 253.770
- +3.920+1.57%
Close Feb 28 16:00 ET
- 254.000
- +0.230+0.09%
Post 20:01 ET
91.45BMarket Cap26.24P/E (TTM)
254.400High249.660Low2.16MVolume251.600Open249.850Pre Close544.65MTurnover0.60%Turnover Ratio26.24P/E (Static)360.36MShares254.40052wk High3.45P/B91.07BFloat Cap184.21252wk Low10.40Dividend TTM358.85MShs Float254.400Historical High4.10%Div YieldTTM1.90%Amplitude3.108Historical Low252.441Avg Price1Lot Size
CME Group Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 6.85%3.69B | -2.53%1.02B | 17.08%1B | 19.45%776.9M | -1.07%892.7M | 13.02%3.45B | 6.40%1.04B | 30.24%856.7M | 5.31%650.4M | 12.93%902.4M |
| Net income from continuing operations | 9.29%3.53B | 7.37%874.6M | 21.67%912.8M | 13.58%883.2M | -3.24%855.2M | 19.89%3.23B | 27.70%814.6M | 10.39%750.2M | 17.37%777.6M | 24.30%883.8M |
| Operating gains losses | 95.01%-3.6M | 2,800.00%8.1M | --0 | -936.36%-9.2M | 96.66%-2.5M | -1,402.08%-72.1M | 57.14%-300K | 272.73%1.9M | 120.00%1.1M | -2,037.14%-74.8M |
| Depreciation and amortization | -4.48%336.8M | -3.36%83.4M | -4.98%83.9M | -5.71%84.2M | -3.83%85.3M | -2.76%352.6M | -4.75%86.3M | -1.89%88.3M | -0.89%89.3M | -3.48%88.7M |
| Deferred tax | 11.47%-66.4M | 9.55%-44.5M | 13.95%-7.4M | 16.47%-7.1M | 14.94%-7.4M | -223.28%-75M | -4,372.73%-49.2M | 14.85%-8.6M | -23.19%-8.5M | -70.59%-8.7M |
| Other non cash items | -108.72%-3M | -81.75%2.3M | -24.07%12.3M | -105.83%-21.2M | -77.36%3.6M | -16.71%34.4M | -70.21%12.6M | 357.14%16.2M | 29.93%-10.3M | -20.50%15.9M |
| Change In working capital | -98.11%-188.6M | -57.12%66.9M | -85.29%-18.9M | 21.30%-171.8M | -185.46%-64.8M | 0.00%-95.2M | -16.58%156M | 91.03%-10.2M | -63.77%-218.3M | 35.51%-22.7M |
| -Change in receivables | 23.50%-39.4M | 138.46%55.8M | -172.79%-29.7M | -77.77%27.9M | 61.28%-93.4M | -0.78%-51.5M | -75.70%23.4M | 6,700.00%40.8M | 382.69%125.5M | -38.62%-241.2M |
| -Change in payables and accrued expense | -18.72%-128.1M | -185.47%-39.4M | 124.40%8.2M | 29.02%-268.8M | -33.45%171.9M | -43.29%-107.9M | -0.43%46.1M | 66.86%-33.6M | -73.64%-378.7M | 30.52%258.3M |
| -Change in other current assets | 235.62%740.2M | 120.62%103.4M | 71.93%-22.6M | 616.09%195.6M | 525.91%463.8M | -5,298.10%-545.8M | -1,266.49%-501.5M | -670.92%-80.5M | -145.23%-37.9M | 246.15%74.1M |
| -Change in other current liabilities | -224.80%-761.3M | -109.00%-52.9M | -60.06%25.2M | -273.76%-126.5M | -433.01%-607.1M | 2,846.86%610M | 625.03%588M | 333.70%63.1M | 391.20%72.8M | -1,255.95%-113.9M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 6.85%3.69B | -2.53%1.02B | 17.08%1B | 19.45%776.9M | -1.07%892.7M | 13.02%3.45B | 6.40%1.04B | 30.24%856.7M | 5.31%650.4M | 12.93%902.4M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -495.22%-82.6M | -24.02%-25.3M | -51.28%-29.5M | -106.41%-5M | -32.56%-22.8M | 104.27%20.9M | 20.62%-20.4M | 17.37%-19.5M | 118.68%78M | 24.89%-17.2M |
| Net PPE purchase and sale | -23.04%-94M | -25.96%-26.2M | -49.75%-29.8M | 11.22%-18.2M | -30.26%-19.8M | 14.83%-76.4M | 14.75%-20.8M | 17.08%-19.9M | -14.53%-20.5M | 35.04%-15.2M |
| Net business purchase and sale | -89.63%9.9M | -86.21%13.5M | --0 | ---100K | -45.83%-3.5M | 123.76%95.5M | 975.82%97.9M | --0 | --0 | ---2.4M |
| Net investment purchase and sale | -16.67%1.5M | 87.08%-12.6M | -25.00%300K | -86.50%13.3M | 25.00%500K | -5.26%1.8M | -837.50%-97.5M | 0.00%400K | 764.04%98.5M | -20.00%400K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -495.22%-82.6M | -24.02%-25.3M | -51.28%-29.5M | -106.41%-5M | -32.56%-22.8M | 104.27%20.9M | 20.62%-20.4M | 17.37%-19.5M | 118.68%78M | 24.89%-17.2M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 110.50%5.08B | -138.02%-984.1M | 150.43%13.35B | 39.57%-9.22B | 121.05%1.94B | -90.45%-48.34B | 150.84%2.59B | -2,380.44%-26.47B | 48.56%-15.26B | -211.88%-9.2B |
| Net issuance payments of debt | --0 | --0 | --0 | ---- | ---- | -7.89%-16.4M | --0 | --0 | ---- | ---- |
| Cash dividends paid | -10.78%-3.58B | -4.67%-418.8M | -4.63%-418.5M | -4.68%-418.5M | -14.38%-2.33B | -22.86%-3.24B | -10.07%-400.1M | -10.13%-400M | -10.05%-399.8M | -31.88%-2.04B |
| Net other financing activities | 119.21%8.66B | -118.92%-565.3M | 152.81%13.77B | 40.70%-8.8B | 159.54%4.26B | -98.33%-45.09B | 163.21%2.99B | -1,810.64%-26.07B | 49.34%-14.85B | -173.25%-7.16B |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 110.50%5.08B | -138.02%-984.1M | 150.43%13.35B | 39.57%-9.22B | 121.05%1.94B | -90.45%-48.34B | 150.84%2.59B | -2,380.44%-26.47B | 48.56%-15.26B | -211.88%-9.2B |
| Net cash flow | ||||||||||
| Beginning cash position | -32.52%93.11B | 13.73%101.79B | -24.03%87.47B | -26.03%95.92B | -32.52%93.11B | -14.19%137.97B | -37.02%89.5B | -17.95%115.13B | -23.63%129.66B | -14.19%137.97B |
| Current changes in cash | 119.36%8.68B | -99.76%8.5M | 155.87%14.32B | 41.85%-8.45B | 133.76%2.81B | -96.64%-44.86B | 187.35%3.61B | -1,527.99%-25.63B | 50.69%-14.53B | -192.39%-8.31B |
| End cash Position | 9.33%101.79B | 9.33%101.79B | 13.73%101.79B | -24.03%87.47B | -26.03%95.92B | -32.52%93.11B | -32.52%93.11B | -37.02%89.5B | -17.95%115.13B | -23.63%129.66B |
| Free cash flow | 6.49%3.6B | -3.11%991.7M | 16.30%973.2M | 20.45%758.7M | -1.61%872.9M | 13.86%3.38B | 6.94%1.02B | 32.03%836.8M | 5.04%629.9M | 14.37%887.2M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Discussing
Widespread uptick! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. Chinese stocks l
Moomoo News Global
Feb 24 22:30
Chinese Stocks' Wild Rally Hits Pause? Wall Street Still Bets Big on Favorites